Amos Bar-Shalev insider trades: Protalix BioTherapeutics (PLX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Amos reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | PLX | ↓ Sell | 168 | $1.87 | $314 | Direct | Nov 19, 2025 (1d) |
| Dec 2, 2009 | PLX | ↑ Buy | 1,680 | $8.49 | $14K | Direct | Dec 9, 2009 (7d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PLX insiders
Open-market trades in the last 12 months
About Amos Bar-Shalev's insider trades
Amos Bar-Shalev is an insider at Protalix BioTherapeutics (PLX). Since Dec 2, 2009, Amos has reported 1 open-market purchase worth $14K and 1 sale worth $314 on SEC Form 4. In the last 12 months: 1 sale ($314).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PLX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.